RESUMEN

The efficacy of cetirizine, 10 mg once daily, in the treatment of seasonal allergic rhinoconjunctivitis was evaluated in a double-blind placebo-controlled trial. Sixteen patients monosensitized to olive pollen were treated simultaneously for 6 weeks, including one pollen season. Severity of symptoms and rescue drug consumption were significantly lower in the cetirizine group.

Asunto(s)

Conjuntivitis Alérgica/tratamiento farmacológico , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Hidroxizina/análogos & derivados , Rinitis Alérgica Estacional/tratamiento farmacológico , Adulto , Cetirizina , Ensayos Clínicos como Asunto , Conjuntivitis Alérgica/complicaciones , Método Doble Ciego , Humanos , Hidroxizina/uso terapéutico , Placebos , Rinitis Alérgica Estacional/complicaciones